loading

Finanzdaten der Repare Therapeutics Inc-Aktie (RPTX)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-09-30 2024-06-30 2024-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
5.916
- - 1.073 52.40
Operating Expenses
24.02%
23.70
31.19 36.37 38.39 41.59
Benefits Costs and Expenses
24.47%
22.41
29.67 33.92 35.52 38.61
Costs And Expenses
24.02%
23.70
31.19 36.37 38.39 41.59
Operating Income/Loss
42.99%
-17.78
-31.19 -36.37 -37.32 10.82
Nonoperating Income/Loss
15.19%
1.284
1.514 2.451 2.871 2.975
Income/Loss From Continuing Operations Before Tax
44.41%
-16.50
-29.67 -33.92 -34.45 13.79
Income Tax Expense/Benefit
32.97%
0.248
0.37 0.485 0.326 0.629
Income/Loss From Continuing Operations After Tax
44.27%
-16.74
-30.04 -34.41 -34.77 13.16
Net Income/Loss
44.27%
-16.74
-30.04 -34.41 -34.77 13.16
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.78%
42.92
42.59 42.45 42.45 42.23
Diluted Average Shares
0.78%
42.92
42.59 42.45 42.45 44.02
Basic Earnings Per Share
45.07%
-0.39
-0.71 -0.81 -0.82 0.31
Diluted Earnings Per Share
45.07%
-0.39
-0.71 -0.81 -0.82 0.30
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$86.64
price up icon 1.40%
$27.54
price up icon 0.58%
$25.98
price up icon 9.16%
$112.46
price up icon 8.66%
$145.10
price up icon 1.80%
biotechnology ONC
$341.80
price up icon 7.24%
Kapitalisierung:     |  Volumen (24h):